Using a smartphone app to help patients with alcohol-related liver disease stop drinking.
Testing an mHealth System for Integrating Alcohol Use Treatment with Hepatology Care for Patients with Alcohol-associated Liver Disease
This study is testing a smartphone app that helps people with alcohol-related liver disease cut down on drinking, and it’s designed for patients who want extra support alongside their regular medical care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10932395 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of a smartphone application designed to support alcohol cessation in patients with alcohol-associated liver disease (ALD). It aims to integrate alcohol use treatment with hepatology care, addressing the significant gap in treatment access for ALD patients. The study will involve a randomized, controlled trial where patients will receive the app alongside their regular medical care to evaluate its impact on reducing alcohol consumption. By focusing on both behavioral intervention and medical treatment, the research seeks to improve patient outcomes and reduce the burden of ALD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with alcohol-associated liver disease who are seeking help to reduce or stop their alcohol consumption.
Not a fit: Patients who are not diagnosed with alcohol-associated liver disease or those who are not interested in reducing their alcohol intake may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to effective alcohol cessation treatment for patients with alcohol-associated liver disease.
How similar studies have performed: Previous research has shown that integrated behavioral interventions for alcohol cessation can be effective, suggesting a promising avenue for this approach.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Quanbeck, Andrew — University of Wisconsin-Madison
- Study coordinator: Quanbeck, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.